The fringe benefits of cloning cancer.
Where this comes from
- Record sourced from PubMed, PMID 25232174.
- Also identified by DOI 10.1126/scitranslmed.3010174.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A new approach to monitoring tumor clone dynamics (Carreira et al., this issue) uses sequential biopsies and circulating DNA to help optimize treatment in metastatic prostate cancer.
Medical subject headings
- Clone Cells
- Prostatic Neoplasms